Ann: Quarterly Cashflow and Market Update September 2021, page-16

First 16 Last

Share
Profile

Follow
hoofa

12,658 Posts.

1817

29/10/21

16:26

Post #: 57186974
Share

Originally posted by Scott th Ratbag ↑

thank you for your intervention in HC, this doesn't change the situation that is the principle of my reaction to the 4C.

the Neuvis (that's how long its been since we've seen anything on the Auscann medical cannabis efforts that I forgot the correct spelling) news is welcome - why wasn't this explained, spelled out in previous announcements? Why has Neuvis been allowed to wallow with no support to strengthen the progress of the medication to broader registration? As this was the key driver of Auscann development until Cannpal took over, why were we not kept informed of developments?

Even the hard shell caps have not been mentioned since the t/o, yet you now describe the caps as "the key intellectual property". This would imply the importance of the caps, yet this too has been neglected in announcements.

the SP has languished with the lack of news, yet no comment on the reduced valuation of the company. no apparent effort to support the interest of new investors or to encourage the understanding of current investors of progress, leaving all to your chief cheerleader.

Given the fallen SP and the absence of comments on the thread by former regular posters. the perspective that many Auscann holders have left the building. this can be easily extrapolated to the broader Auscann holders and raises the question wrt the concentration of shareholdings.

I've frankly had enough of the lack of attention your leadership has provided to holders, your lack of communication on the matters related to earning revenue, other than your pursuit of the veterinary treatments.

I'm taking a loss and getting the hell out of this company.

Expand

Patience Scott, you will be rewarded.
Accept the process and your ride will be a profitable journey.
Cheers.

AC8 Price at posting: 10.0¢ Sentiment: Buy Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

RAD

Radiopharm extends radioimmunotherapy trial to 5 more cancer types

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

PAM

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

SGP

Things finally 'looking different' for up-and-down Hot Stock tip Stockland